1. Antiviral activity of PHA767491 on Caprine alphaherpesvirus 1 in vitro
- Author
-
Canio Buonavoglia, Claudia Zizzadoro, Maria Tempesta, Gianvito Lanave, Maria Stella Lucente, Paolo Trerotoli, Vito Martella, Pietro Siciliano, and Michele Camero
- Subjects
Simplexvirus ,food.ingredient ,040301 veterinary sciences ,viruses ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Cell Line ,0403 veterinary science ,03 medical and health sciences ,Dogs ,food ,In vivo ,Homologous chromosome ,medicine ,Animals ,Pyrroles ,Varicellovirus ,Dna viral ,Piperidones ,030304 developmental biology ,0303 health sciences ,General Veterinary ,biology ,04 agricultural and veterinary sciences ,biology.organism_classification ,Virology ,In vitro ,Caprine alphaherpesvirus 1 ,Herpes simplex virus ,DNA, Viral - Abstract
Caprine alphaherpesvirus 1 (CpHV-1) induces genital lesions in its natural host similar to those caused by Human alphaherpesvirus 2 (HHV-2), commonly named herpes simplex virus 2 (HSV-2) in human patients. CpHV-1 infection in goats could represent a useful homologous animal model for the study of HSV-2 infection, chiefly for the assessment of antiviral drugs in in vivo studies. PHA767491 is a potent inhibitor of HSV-1 and HSV-2, being able to limit replication of HHVs both in vitro and in the mouse model. In the present study the antiviral efficacy of PHA767491 against CpHV-1 was evaluated in vitro in MDBK cells. PHA767491 inhibited significantly CpHV-1 replication in a dose-dependent fashion by up to 2.50 log10 TCID50/50 μl and was able to decrease viral DNA by nearly 8 log10. These findings confirm that PHA767491 is highly effective not only against simplexviruses (HSV-1 and HSV-2), but also against the varicellovirus CpHV-1. Experiments will be necessary to assess whether PHA767491 is suitable for treatment of vaginal lesions in CpHV-1-goat model. This could provide hints for the therapy of genital alphaherpesvirus infections in humans.
- Published
- 2019
- Full Text
- View/download PDF